Wolves in Sheep’s Clothing
Transparency Talkers, Accountability Dodgers
Isn’t it rich? The same PBMs that spent years pillaging payer budgets now parade around as prophets of transparency—shouting “clarity” from the rooftops like they just discovered sunlight.
But beware the rebrand. Today’s PBM landscape is full of “transparency” models that are anything but. There are shades of openness, gradients of clarity, and just enough polish to pass as progress.
Here’s the truth: some PBMs have learned to talk the talk, but what they’re offering is a distinction without a difference. The costume has changed, but the playbook hasn’t.
So how do you know if your PBM is just putting on a show?
Here are three tests to separate the real from the rehearsed:
Do you know—really know—your true program costs?
Not averages. Not anecdotes. Actual, all-in, claim-by-claim cost visibility.Do you have access to raw, unfiltered data?
Not scrubbed reports or dashboards designed for optics. The truth is in the raw feed.Is your PBM acting like a real partner—or a vendor with a thesaurus?
Do they solve problems or just explain them away?
— ALWAYS READ THE FINE PRINT!
Forget the glossy portals and the polished pitch decks. At Prodigy, we believe transparency isn't something you perform—it’s something you prove.
We put our stake in the ground. Whether it’s turnaround time, clinical outreach, financial guarantees, or real-time reporting, we build accountability into every contract with SLAs and performance guarantees. No fluff. Just stakes, skin, and standards.
Ask yourself:
Does your PBM have skin in the game?
Can you hold them accountable in writing?
Are you actually satisfied with the status quo?
If you hesitated—or said no—to any of these, it might be time to explore a smarter alternative.
📞 Call me for a virtual consult. No pressure. Just clarity.
I promise—it’ll be worth your while.
About P4P
A Strategic Dose of Clarity in a Noisy PBM Market
Written by Prodigy CEO Del, P4P delivers sharp, consultative insights for decision-makers who are tired of legacy models, hidden costs, and passive vendors. Each piece is a prescription—cutting through the noise to reveal what actually drives performance in pharmacy benefit management.
No fluff. No spin. Just insight that pays off.
